APO RESEARCH · REPORT
Pre-Sterilized Syringe
Pre-sterilized syringes are syringe devices processed and packaged to maintain a specified sterile condition before their intended use or downstream filling operation.

Product & engineering
Understand the product.
Pre-sterilized does not mean prefilled. Distinguish the empty-device sterilisation process from filling, container closure and finished-product validation.
What turns activity into demand
Device demand is defined by container or delivery function, connection, materials and validated manufacturing. Prefilling adds formulation compatibility and storage integrity to the device boundary.
The commercial boundary
Injection, enteral, oral and analytical devices have different interfaces and intended uses. Representative images establish neither sterility nor clinical suitability.
What establishes sterile condition beyond appearance?
Pre-sterilized does not mean prefilled. Distinguish the empty-device sterilisation process from filling, container closure and finished-product validation.
Selected research
Market Structure
Global Pre-Sterilized Syringe Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Pre-Sterilized Syringe market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Pre-Sterilized Syringe is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Pre-Sterilized Syringe is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Pre-Sterilized Syringe is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Pre-Sterilized Syringe is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Pre-Sterilized Syringe include BD, Gerresheimer, Nipro Corporation, Schott, Stevanato, Simtra (Baxter), Rovi CM, Terumo and Vetter, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Pre-Sterilized Syringe market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Pre-Sterilized Syringe and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Pre-Sterilized Syringe sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pre-Sterilized Syringe market size, projected growth trends, production technologies, key applications, and end-use industries.
Pre-Sterilized Syringe Segment by Company
BD
Gerresheimer
Nipro Corporation
Schott
Stevanato
Simtra (Baxter)
Rovi CM
Terumo
Vetter
Catalent
Taisei Kako
J.O.Pharma
West Pharma
Weigao Group
Shandong Zibo Minkang
Shandong Pharmaceutical Glass
Ningbo Zhengli
Shandong Ujoin
Pre-Sterilized Syringe Segment by Type
Glass Type
Plastic Type
Pre-Sterilized Syringe Segment by Application
Vaccine
Antithrombotic Drugs
Bioengineered Drugs
Other (Beauty, etc.)
Pre-Sterilized Syringe Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pre-Sterilized Syringe market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pre-Sterilized Syringe and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pre-Sterilized Syringe.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Pre-Sterilized Syringe market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pre-Sterilized Syringe manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pre-Sterilized Syringe in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Pre-Sterilized Syringe in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Glass Type
- Plastic Type
Applications
- Vaccine
- Antithrombotic Drugs
- Bioengineered Drugs
- Other (Beauty, etc.)
Companies covered
- BD
- Gerresheimer
- Nipro Corporation
- Schott
- Stevanato
- Simtra (Baxter)
- Rovi CM
- Terumo
- Vetter
- Catalent
- Taisei Kako
- J.O.Pharma
- West Pharma
- Weigao Group
- Shandong Zibo Minkang
- Shandong Pharmaceutical Glass
- Ningbo Zhengli
- Shandong Ujoin
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Pre-Sterilized Syringe Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Pre-Sterilized Syringe Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Pre-Sterilized Syringe Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Pre-Sterilized Syringe Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Pre-Sterilized Syringe Market Dynamics
- 2.1 Pre-Sterilized Syringe Industry Trends
- 2.2 Pre-Sterilized Syringe Industry Drivers
- 2.3 Pre-Sterilized Syringe Industry Opportunities and Challenges
- 2.4 Pre-Sterilized Syringe Industry Restraints
3 Pre-Sterilized Syringe Market by Manufacturers
- 3.1 Global Pre-Sterilized Syringe Revenue by Manufacturers (2021-2026)
- 3.2 Global Pre-Sterilized Syringe Sales by Manufacturers (2021-2026)
- 3.3 Global Pre-Sterilized Syringe Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Pre-Sterilized Syringe Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Pre-Sterilized Syringe Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Pre-Sterilized Syringe Manufacturers, Product Type & Application
- 3.7 Global Pre-Sterilized Syringe Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Pre-Sterilized Syringe Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Pre-Sterilized Syringe Players Market Share by Revenue in 2025
- 3.8.3 2025 Pre-Sterilized Syringe Tier 1, Tier 2, and Tier 3
4 Pre-Sterilized Syringe Market by Type
- 4.1 Pre-Sterilized Syringe Type Introduction
- 4.1.1 Glass Type
- 4.1.2 Plastic Type
- 4.2 Global Pre-Sterilized Syringe Sales by Type
- 4.2.1 Global Pre-Sterilized Syringe Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Pre-Sterilized Syringe Sales by Type (2021-2032)
- 4.2.3 Global Pre-Sterilized Syringe Sales Market Share by Type (2021-2032)
- 4.3 Global Pre-Sterilized Syringe Revenue by Type
- 4.3.1 Global Pre-Sterilized Syringe Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Pre-Sterilized Syringe Revenue by Type (2021-2032)
- 4.3.3 Global Pre-Sterilized Syringe Revenue Market Share by Type (2021-2032)
5 Pre-Sterilized Syringe Market by Application
- 5.1 Pre-Sterilized Syringe Application Introduction
- 5.1.1 Vaccine
- 5.1.2 Antithrombotic Drugs
- 5.1.3 Bioengineered Drugs
- 5.1.4 Other (Beauty, etc.)
- 5.2 Global Pre-Sterilized Syringe Sales by Application
- 5.2.1 Global Pre-Sterilized Syringe Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Pre-Sterilized Syringe Sales by Application (2021-2032)
- 5.2.3 Global Pre-Sterilized Syringe Sales Market Share by Application (2021-2032)
- 5.3 Global Pre-Sterilized Syringe Revenue by Application
- 5.3.1 Global Pre-Sterilized Syringe Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Pre-Sterilized Syringe Revenue by Application (2021-2032)
- 5.3.3 Global Pre-Sterilized Syringe Revenue Market Share by Application (2021-2032)
6 Global Pre-Sterilized Syringe Sales by Region
- 6.1 Global Pre-Sterilized Syringe Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Pre-Sterilized Syringe Sales by Region (2021-2032)
- 6.2.1 Global Pre-Sterilized Syringe Sales by Region (2021-2026)
- 6.2.2 Global Pre-Sterilized Syringe Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Pre-Sterilized Syringe Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Pre-Sterilized Syringe Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Pre-Sterilized Syringe Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Pre-Sterilized Syringe Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Pre-Sterilized Syringe Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Pre-Sterilized Syringe Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Pre-Sterilized Syringe Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Pre-Sterilized Syringe Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Pre-Sterilized Syringe Revenue by Region
- 7.1 Global Pre-Sterilized Syringe Revenue by Region
- 7.1.1 Global Pre-Sterilized Syringe Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Pre-Sterilized Syringe Revenue by Region (2021-2026)
- 7.1.3 Global Pre-Sterilized Syringe Revenue by Region (2027-2032)
- 7.1.4 Global Pre-Sterilized Syringe Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Pre-Sterilized Syringe Revenue (2021-2032)
- 7.2.2 North America Pre-Sterilized Syringe Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Pre-Sterilized Syringe Revenue (2021-2032)
- 7.3.2 Europe Pre-Sterilized Syringe Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Pre-Sterilized Syringe Revenue (2021-2032)
- 7.4.2 Asia-Pacific Pre-Sterilized Syringe Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Pre-Sterilized Syringe Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Pre-Sterilized Syringe Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 BD
- 8.1.1 BD Company Information
- 8.1.2 BD Business Overview
- 8.1.3 BD Pre-Sterilized Syringe Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 BD Pre-Sterilized Syringe Product Portfolio
- 8.1.5 BD Recent Developments
- 8.2 Gerresheimer
- 8.2.1 Gerresheimer Company Information
- 8.2.2 Gerresheimer Business Overview
- 8.2.3 Gerresheimer Pre-Sterilized Syringe Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Gerresheimer Pre-Sterilized Syringe Product Portfolio
- 8.2.5 Gerresheimer Recent Developments
- 8.3 Nipro Corporation
- 8.3.1 Nipro Corporation Company Information
- 8.3.2 Nipro Corporation Business Overview
- 8.3.3 Nipro Corporation Pre-Sterilized Syringe Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Nipro Corporation Pre-Sterilized Syringe Product Portfolio
- 8.3.5 Nipro Corporation Recent Developments
- 8.4 Schott
- 8.4.1 Schott Company Information
- 8.4.2 Schott Business Overview
- 8.4.3 Schott Pre-Sterilized Syringe Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Schott Pre-Sterilized Syringe Product Portfolio
- 8.4.5 Schott Recent Developments
- 8.5 Stevanato
- 8.5.1 Stevanato Company Information
- 8.5.2 Stevanato Business Overview
- 8.5.3 Stevanato Pre-Sterilized Syringe Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Stevanato Pre-Sterilized Syringe Product Portfolio
- 8.5.5 Stevanato Recent Developments
- 8.6 Simtra (Baxter)
- 8.6.1 Simtra (Baxter) Company Information
- 8.6.2 Simtra (Baxter) Business Overview
- 8.6.3 Simtra (Baxter) Pre-Sterilized Syringe Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Simtra (Baxter) Pre-Sterilized Syringe Product Portfolio
- 8.6.5 Simtra (Baxter) Recent Developments
- 8.7 Rovi CM
- 8.7.1 Rovi CM Company Information
- 8.7.2 Rovi CM Business Overview
- 8.7.3 Rovi CM Pre-Sterilized Syringe Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Rovi CM Pre-Sterilized Syringe Product Portfolio
- 8.7.5 Rovi CM Recent Developments
- 8.8 Terumo
- 8.8.1 Terumo Company Information
- 8.8.2 Terumo Business Overview
- 8.8.3 Terumo Pre-Sterilized Syringe Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Terumo Pre-Sterilized Syringe Product Portfolio
- 8.8.5 Terumo Recent Developments
- 8.9 Vetter
- 8.9.1 Vetter Company Information
- 8.9.2 Vetter Business Overview
- 8.9.3 Vetter Pre-Sterilized Syringe Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Vetter Pre-Sterilized Syringe Product Portfolio
- 8.9.5 Vetter Recent Developments
- 8.10 Catalent
- 8.10.1 Catalent Company Information
- 8.10.2 Catalent Business Overview
- 8.10.3 Catalent Pre-Sterilized Syringe Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Catalent Pre-Sterilized Syringe Product Portfolio
- 8.10.5 Catalent Recent Developments
- 8.11 Taisei Kako
- 8.11.1 Taisei Kako Company Information
- 8.11.2 Taisei Kako Business Overview
- 8.11.3 Taisei Kako Pre-Sterilized Syringe Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Taisei Kako Pre-Sterilized Syringe Product Portfolio
- 8.11.5 Taisei Kako Recent Developments
- 8.12 J.O.Pharma
- 8.12.1 J.O.Pharma Company Information
- 8.12.2 J.O.Pharma Business Overview
- 8.12.3 J.O.Pharma Pre-Sterilized Syringe Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 J.O.Pharma Pre-Sterilized Syringe Product Portfolio
- 8.12.5 J.O.Pharma Recent Developments
- 8.13 West Pharma
- 8.13.1 West Pharma Company Information
- 8.13.2 West Pharma Business Overview
- 8.13.3 West Pharma Pre-Sterilized Syringe Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 West Pharma Pre-Sterilized Syringe Product Portfolio
- 8.13.5 West Pharma Recent Developments
- 8.14 Weigao Group
- 8.14.1 Weigao Group Company Information
- 8.14.2 Weigao Group Business Overview
- 8.14.3 Weigao Group Pre-Sterilized Syringe Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Weigao Group Pre-Sterilized Syringe Product Portfolio
- 8.14.5 Weigao Group Recent Developments
- 8.15 Shandong Zibo Minkang
- 8.15.1 Shandong Zibo Minkang Company Information
- 8.15.2 Shandong Zibo Minkang Business Overview
- 8.15.3 Shandong Zibo Minkang Pre-Sterilized Syringe Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 Shandong Zibo Minkang Pre-Sterilized Syringe Product Portfolio
- 8.15.5 Shandong Zibo Minkang Recent Developments
- 8.16 Shandong Pharmaceutical Glass
- 8.16.1 Shandong Pharmaceutical Glass Company Information
- 8.16.2 Shandong Pharmaceutical Glass Business Overview
- 8.16.3 Shandong Pharmaceutical Glass Pre-Sterilized Syringe Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.16.4 Shandong Pharmaceutical Glass Pre-Sterilized Syringe Product Portfolio
- 8.16.5 Shandong Pharmaceutical Glass Recent Developments
- 8.17 Ningbo Zhengli
- 8.17.1 Ningbo Zhengli Company Information
- 8.17.2 Ningbo Zhengli Business Overview
- 8.17.3 Ningbo Zhengli Pre-Sterilized Syringe Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.17.4 Ningbo Zhengli Pre-Sterilized Syringe Product Portfolio
- 8.17.5 Ningbo Zhengli Recent Developments
- 8.18 Shandong Ujoin
- 8.18.1 Shandong Ujoin Company Information
- 8.18.2 Shandong Ujoin Business Overview
- 8.18.3 Shandong Ujoin Pre-Sterilized Syringe Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.18.4 Shandong Ujoin Pre-Sterilized Syringe Product Portfolio
- 8.18.5 Shandong Ujoin Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Pre-Sterilized Syringe Value Chain Analysis
- 9.1.1 Pre-Sterilized Syringe Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Pre-Sterilized Syringe Production Mode & Process
- 9.2 Pre-Sterilized Syringe Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Pre-Sterilized Syringe Distributors
- 9.2.3 Pre-Sterilized Syringe Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst